CHICAGO, Ill. -- By Kim Ji-hye / Korea Biomedical correspondent -- They met in the middle of the exhibit hall at Chicago’s ...

GSK’s Jemperli has secured its position as a standard treatment option in endometrial cancer following Korea’s decision to ...

Last week, the Ministry of Health and Welfare announced plans to improve the drug pricing system, aiming to establish an ...

GC Holdings announced Monday that it has appointed Park So-young as the new head of its Strategic Planning Office.Park is a ...

The Korean Stroke Society has proposed that to reduce the problem of stroke patients being shuttled between emergency rooms, ...

Recently, the Korean Pharmaceutical Association advocated ingredient-name prescribing, citing annual savings of trillions of ...

Samsung Biologics said it will push ahead with a broader contract development and manufacturing organization (CDMO) portfolio ...

AstraZeneca Korea's C5 inhibitor Ultomiris (ravulizumab) became reimbursed by the national health insurance for adult ...

The government has unveiled a large-scale overhaul of the health insurance drug pricing system, proposing flexible ...

Celltrion said it secured formulary placement for its bone-disease treatments Stoboclo and Osenvelt (ingredient: denosumab) ...

The impact of the Tattoo Artist Act, enacted last October, has been confirmed. A guilty verdict handed down in July for ...

Recent five-year results presented at the European Society for Medical Oncology (ESMO 2025) showed that perioperative ...